Understanding glial cells: Implications for multiple sclerosis pathogenesis and therapeutics

Area of Science:

• Neuroimmunology
• Cellular Biology
• Neurology

Background:

• Multiple sclerosis (MS) is linked to glial cell (astrocytes, oligodendrocytes, microglia) dysfunction.
• MS prevalence is rising in India, impacting patients' social and family well-being.
• Glial cells are crucial for neuronal function, homeostasis, and neuroinflammation.

Purpose of the Study:

• To review the role of glial cells in multiple sclerosis pathology.
• To examine current therapeutic strategies for MS.
• To explore potential future therapeutics targeting glial cells.

Main Methods:

• Comprehensive literature survey.
• Analysis of glial cell pathways in MS pathogenesis (demyelination, astrocytosis, microglial activation).
• Review of existing disease-modifying and symptomatic treatments.
• Exploration of novel therapeutic avenues like remyelination and immunomodulation.

Main Results:

• Glial cell dysfunction significantly contributes to MS pathogenesis and progression.
• Current treatments focus on disease modification and symptom management.
• Emerging strategies target glial cells for remyelination and immunomodulation.

Conclusions:

• Understanding the glial cell-immune system interplay is vital for MS.
• Targeting glial cells offers potential for more individualized and effective MS therapies.
• Further research into glial cell function can advance MS management.